title: Pharmacokinetics of gabapentin in cats.
abstract: OBJECTIVE
  To determine the pharmacokinetics of gabapentin in cats after IV and oral administration.
  
  
  METHODS
  6 healthy female adult domestic shorthair cats.
  
  
  METHODS
  Gabapentin was administered IV (4 mg/kg) or orally (10 mg/kg) in a crossover randomized design. Blood samples were obtained immediately before gabapentin administration and at various times up to 960 minutes after IV administration or up to 1,440 minutes after oral administration. Blood samples were immediately transferred to tubes that contained EDTA and were centrifuged at 4 degrees C. Plasma was harvested and stored at -20 degrees C until analysis. Plasma concentrations of gabapentin were determined by use of liquid chromatography-mass spectrometry. Gabapentin concentration-time data were fit to compartment models.
  
  
  RESULTS
  A 3-compartment model with elimination from the central compartment best described the disposition of gabapentin administered IV to cats, but a 1-compartment model best described the disposition of gabapentin administered orally to cats. After IV administration, the mean +/- SEM apparent volume of the central compartment, apparent volume of distribution at steady state, and clearance and the harmonic mean +/- jackknife pseudo-SD for terminal half-life were 90.4 +/- 11.3 mL/kg, 650 +/- 14 mL/kg, 3 +/- 0.2 mL/min/kg, and 170 +/- 21 minutes, respectively. Mean +/- SD systemic availability and harmonic mean +/- jackknife pseudo-SD terminal half-life after oral administration were 88.7 +/- 11.1% and 177 +/- 25 minutes, respectively.
  
  
  CONCLUSIONS
  The disposition of gabapentin in cats was characterized by a small volume of distribution and a low clearance.
authors.affiliation: Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USA.
authors.forename: Kristine T
authors.initials: KT
authors.lastname: Siao
authors.forename: Bruno H
authors.initials: BH
authors.lastname: Pypendop
authors.forename: Jan E
authors.initials: JE
authors.lastname: Ilkiw
mesh_terms: D000284:Administration, Oral; D000588:Amines / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D000758:Anesthesia / Q000379:methods / Q000662:veterinary; D000818:Animals; D000927:Anticonvulsants / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics; D002415:Cats; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D005260:Female; D000077206:Gabapentin; D006207:Half-Life; D007275:Injections, Intravenous; D007700:Kinetics; D010052:Ovariectomy / Q000662:veterinary; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*
chemical_list: D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin